[Thrombocyte function during the use of immunosuppressive agents].
D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D003018:Clot Retraction; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007938:Leukemia / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D013916:Thrombelastography; D014750:Vincristine / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate
Thrombozytenfunktion bei Anwendung von Immunsuppressiva